A Prior Diagnosis of Breast Cancer Is a Risk Factor for Breast Cancer in BRCA1 and BRCA2 Carriers

Current Oncology - Canada
doi 10.3747/co.21.1656
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

MultiMed Inc.

Related search

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer

Cancers
Cancer ResearchOncology
2018English

Plasma Osteoprotegerin and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Oncotarget
Oncology
2016English

Risk Assessment for Hereditary Breast Cancer: BRCA1 and BRCA2

Canadian Oncology Nursing Journal
2010English

Phenotypic Analysis of Familial Breast Cancer: Comparison of BRCAx Tumors With BRCA1-, BRCA2-carriers and Non-Familial Breast Cancer

European Journal of Surgical Oncology
MedicineOncologySurgery
2015English

Risk-Reducing Salpingo-Oophorectomy, Natural Menopause, and Breast Cancer Risk: An International Prospective Cohort of BRCA1 and BRCA2 Mutation Carriers

Breast Cancer Research
Cancer ResearchOncology
2020English

Body Weight and Risk of Breast Cancer in BRCA1/2 Mutation Carriers

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

Cisplatin in Breast Cancer Treatment in BRCA1 Carriers

Hereditary Cancer in Clinical Practice
OncologyGenetics
2012English

Contralateral Mastectomy and Survival After Breast Cancer in Carriers of BRCA1 and BRCA2 Mutations: Retrospective Analysis

British Medical Journal
Medicine
2014English

Management of Breast Cancer Risk in Women With Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations

Annals of Surgical Oncology
OncologySurgery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy